anlak storytelling
All kinds
Document kinds
Loading document kinds...

Primary corpus lens for browsing and insights. Selection lives in the URL.

All formats
Orientation
Loading formats...

Landscape, portrait, square, or unknown document geometry.

Unlock
slides · global inventory

Sequoia Pitch

Arc collection for the active corpus filters, with each row opening the slide detail view.

Search Insights JSON Unlock
Matching slides 43,093
Current window 27,811-27,840
Pages 1,437
Rows per page 30
Arc: Sequoia Pitchclear collectionreset all
18 30 60

Arc

27,811-27,840 of 43,093

filter-aware
05
The chart uses a Gantt-style visualization to represent clinical trial progress.MindMed | Investor Presentation Deck | 42 slides · MindMed
Pitch deck Investor relations Beat · RoadmapLoop · Golden Circle1 hit
06
The slide uses a horizontal timeline format to track clinical trial milestones.MindMed | Investor Presentation Deck | 42 slides · MindMed
Pitch deck Investor relations Beat · RoadmapLoop · Golden Circle1 hit
09
The slide uses a 3x2 matrix structure to contrast clinical efficacy, market opportunity, and current treatment limitations.MindMed | Investor Presentation Deck | 42 slides · MindMed
Pitch deck Investor relations Beat · ProblemLoop · Cost Of Inaction1 hit
10
Uses a process-flow diagram to illustrate biological mechanism.MindMed | Investor Presentation Deck | 42 slides · MindMed
Pitch deck Investor relations Beat · SolutionLoop · Cost Of Inaction1 hit
16
The slide uses a bar chart to compare effect sizes (Cohen's d) across four treatment categories.MindMed | Investor Presentation Deck | 42 slides · MindMed
Pitch deck Investor relations Beat · TractionLoop · Golden Circle1 hit
17
The slide uses a list-based framework to map clinical outcomes to target product profile attributes.MindMed | Investor Presentation Deck | 42 slides · MindMed
Pitch deck Investor relations Beat · TractionLoop · Golden Circle1 hit
18
The slide outlines two distinct study protocols with specific sample sizes and dosing regimens, including a primary endpoint at week 12.MindMed | Investor Presentation Deck | 42 slides · MindMed
Pitch deck Investor relations Beat · TractionLoop · Golden Circle1 hit
19
Includes study timeline, randomization, entry criteria, and endpoints.MindMed | Investor Presentation Deck | 42 slides · MindMed
Pitch deck Investor relations Beat · TractionLoop · Golden Circle1 hit
20
Shows a process flow between follow-up observation and potential treatment based on clinical criteria.MindMed | Investor Presentation Deck | 42 slides · MindMed
Pitch deck Investor relations Beat · TractionLoop · Golden Circle1 hit
21
Includes logos for Voyage and Panorama studies; references statistical power assumptions in footnotes.MindMed | Investor Presentation Deck | 42 slides · MindMed
Pitch deck Investor relations Beat · TractionLoop · Golden Circle1 hit
22
MindMed | Investor Presentation Deck | 42 slidesMindMed | Investor Presentation Deck | 42 slides · MindMed
Pitch deck Investor relations Beat · TractionLoop · Golden Circle1 hit
23
The slide uses a table to establish scientific credibility for the company's therapeutic focus.MindMed | Investor Presentation Deck | 42 slides · MindMed
Pitch deck Investor relations Beat · TractionLoop · Golden Circle1 hit
24
The chart displays LS Mean Change from baseline across multiple dose groups (25, 50, 100, 200 ug) versus placebo.MindMed | Investor Presentation Deck | 42 slides · MindMed
Pitch deck Investor relations Beat · TractionLoop · Golden Circle1 hit
25
The slide outlines a clinical trial protocol with a primary endpoint at week 6 and a 40-week extension phase.MindMed | Investor Presentation Deck | 42 slides · MindMed
Pitch deck Investor relations Beat · TractionLoop · Golden Circle1 hit
26
Includes study timeline, randomization details, entry criteria, and secondary endpoints.MindMed | Investor Presentation Deck | 42 slides · MindMed
Pitch deck Investor relations Beat · TractionLoop · Golden Circle1 hit
27
The slide features the MindMed logo and the specific drug candidate and trial phase.MindMed | Investor Presentation Deck | 42 slides · MindMed
Pitch deck Investor relations Beat · TractionLoop · Golden Circle1 hit
28
The slide emphasizes regulatory alignment and standard clinical trial methodology.MindMed | Investor Presentation Deck | 42 slides · MindMed
Pitch deck Investor relations Beat · TractionLoop · Golden Circle1 hit
29
Includes study arms, dosing, follow-up timeline, entry criteria, and secondary endpoints.MindMed | Investor Presentation Deck | 42 slides · MindMed
Pitch deck Investor relations Beat · TractionLoop · Golden Circle1 hit
30
Uses a comparison table to define what is and is not part of the patient journey.MindMed | Investor Presentation Deck | 42 slides · MindMed
Pitch deck Investor relations Beat · TractionLoop · Golden Circle1 hit
31
The slide uses a CONSORT-style flow diagram to track patient retention.MindMed | Investor Presentation Deck | 42 slides · MindMed
Pitch deck Investor relations Beat · TractionLoop · Golden Circle1 hit
32
The table displays mean age, sex distribution, race, and baseline HAM-A and CGI-S scores for n=194 participants.MindMed | Investor Presentation Deck | 42 slides · MindMed
Pitch deck Investor relations Beat · TractionLoop · Golden Circle1 hit
33
The chart highlights the efficacy of the 100ug dose group specifically in the callout box.MindMed | Investor Presentation Deck | 42 slides · MindMed
Pitch deck Investor relations Beat · TractionLoop · Golden Circle1 hit
34
Data compares Placebo, 25ug, 50ug, 100ug, and 200ug doses.MindMed | Investor Presentation Deck | 42 slides · MindMed
Pitch deck Investor relations Beat · TractionLoop · Golden Circle1 hit
26
The chart distinguishes between historical data (dark blue) and projections (grey).SoftBank | Results Presentation Deck | 45 slides · SoftBank
Conference presentation Investor relations Beat · Market SizeLoop · Mece Breakdown1 hit
27
The chart includes a small segment for SB Northstar at the top of each bar.SoftBank | Results Presentation Deck | 45 slides · SoftBank
Conference presentation Investor relations Beat · Market SizeLoop · Mece Breakdown1 hit
28
The chart tracks debt from Sep 2023 to Sep 2024.SoftBank | Results Presentation Deck | 45 slides · SoftBank
Conference presentation Investor relations Beat · Market SizeLoop · Mece Breakdown1 hit
29
The chart tracks credit rating changes from 2003 to 2024, highlighting major acquisitions and listings.SoftBank | Results Presentation Deck | 45 slides · SoftBank
Conference presentation Investor relations Beat · Team1 hit
30
The chart uses a dual-axis approach to show correlation between SBG and the broader market index.SoftBank | Results Presentation Deck | 45 slides · SoftBank
Conference presentation Investor relations Beat · Team1 hit
31
Includes specific financial policy thresholds (LTV < 25%, 2-year bond redemption coverage).SoftBank | Results Presentation Deck | 45 slides · SoftBank
Conference presentation Investor relations Beat · Team1 hit
32
SoftBank | Results Presentation Deck | 45 slidesSoftBank | Results Presentation Deck | 45 slides · SoftBank
Conference presentation Investor relations Beat · Team1 hit